Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA

BACKGROUND: Currently, resistance to tyrosine kinase inhibitors, such as gefitinib, has become a major obstacle in improving the clinical outcome of patients with metastatic and advanced-stage esophageal squamous cell carcinoma (ESCC). While cell behavior can be modulated by long non-coding RNAs (ln...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Min, Ren, Meiping, Li, Yan, Fu, Yuqiong, Deng, Minmin, Li, Changping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063009/
https://www.ncbi.nlm.nih.gov/pubmed/30049286
http://dx.doi.org/10.1186/s13046-018-0845-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063009/
https://www.ncbi.nlm.nih.gov/pubmed/30049286
http://dx.doi.org/10.1186/s13046-018-0845-9

Ejemplares similares